EP Patent

EP2305688A1 — Novel aminoacids derivatives, their process of preparation and their therapeutical uses as MET inhibitors

Assigned to Aix Marseille Universite · Expires 2011-04-06 · 15y expired

What this patent protects

The present invention concerns novel aminoacids derivatives, in particular some aminoacid amides derivatives, their process of preparation and their use for inhibiting Met-triggered disorders, in particular cancer.

USPTO Abstract

The present invention concerns novel aminoacids derivatives, in particular some aminoacid amides derivatives, their process of preparation and their use for inhibiting Met-triggered disorders, in particular cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP2305688A1
Jurisdiction
EP
Classification
—
Expires
2011-04-06
Drug substance claim
No
Drug product claim
No
Assignee
Aix Marseille Universite
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.